SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001062993-19-001799
Filing Date
2019-04-19
Accepted
2019-04-18 18:14:42
Documents
1
Group Members
BALA VENKATARAMANCHRISTOPHER R. MANNINGMAYURA ONE LLCMAYURA TRUST BYELENA EPOVA

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A sched13da.htm SC 13D/A 82460
  Complete submission text file 0001062993-19-001799.txt   84465
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81104 | Film No.: 19756816
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 1055B POWERS PLACE, SECOND FLOOR ALPHARETTA GA 30004
Business Address 1055B POWERS PLACE, SECOND FLOOR ALPHARETTA GA 30004 901-292-3974
AVEGO HEALTHCARE CAPITAL, LLC (Filed by) CIK: 0001718225 (see all company filings)

IRS No.: 472657122 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A